In Q4FY23, the Active pharma intermediates segment revenue stood at INR 1600 mn as against INR 1190 mn in Q4FY22, registering a growth of 34% on a YoY basis. In the API segment, AOL added 40 new customers in FY23. The board approved the CAPEX plan of INR 1900 mn at Ankleshwar, to support future business growth in the API segment.